About Us

Moosun Group

For a Healthier Animal World

Moosun Group, founded in 1995, is a comprehensive high-tech enterprise specializing in the R&D, production, marketing and technical services of veterinary drugs, feed additives and poultry vaccines. With more than 600 employees and a registered capital of USD 38 million, the company operates 18 production lines, covering powder, premix, feed additives, oral solutions, disinfectants, insecticides, granules, injections and vaccines.

VIEW MORE
1995 year

Company Establishment

600 +

Current Employees

38 million

Registered Capital (USD)

18 Articles

Production Line

Products

Our core business encompasses veterinary drugs, feed additives, and poultry vaccines

Vaccines Veterinary drugs Feed Additives Disinfectants

Vaccines

Moosun Group is a comprehensive high-tech enterprise specializing in R&D, production, marketing and technical service for veterinary drug, feed additive and poultry vaccine.

Veterinary drugs

Moosun Group is a comprehensive high-tech enterprise specializing in R&D, production, marketing and technical service for veterinary drug, feed additive and poultry vaccine.

Feed Additives

Moosun Group is a comprehensive high-tech enterprise specializing in R&D, production, marketing and technical service for veterinary drug, feed additive and poultry vaccine.

Disinfectants

Moosun Group is a comprehensive high-tech enterprise specializing in R&D, production, marketing and technical service for veterinary drug, feed additive and poultry vaccine.

Quality and R&D

Our core business encompasses veterinary drugs, feed additives, and poultry vaccines

R&D Idea

The company has built comprehensive R&D and talent development platforms, including a National Enterprise Technology Center, a Postdoctoral Research Station, and an Academician Workstation.

01

Achievements

Moosun Group has obtained 13 National New Veterinary Drug Certificates. The company has accumulated 380 patent applications in China, of which 278 patents have been granted, including 85 invention patents.

02

Research Areas

Based on the company’s strong R&D capabilities, we focus our research on addressing the core challenges faced by global customers.

03

Blog

Our core business encompasses veterinary drugs, feed additives, and poultry vaccines

Egyptian Experts Visit Qixiang Biological for Factory Audit

From August 22 to 25, 2026, a delegation of Egyptian experts visited Qixiang Biological for a four-day on-site factory audit of the company’s poultry vaccine production and R&D base. Mr. Gao Wenming, General Manager of Qixiang Biological, together with all employees, extended the warmest welcome to the Egyptian guests who traveled from afar.

Aug 25,2026

Moosun International Makes a Splendid Appearance at VIV Select China 2026 in Shanghai

On August 21, the three-day VIV Select China 2026 — the Asian International Intensive Animal Husbandry Exhibition — successfully concluded at the Shanghai World Expo Exhibition and Convention Center. The event brought together over 550 premium brand enterprises from the global livestock industry and attracted approximately 26,000 industry professionals for on-site exchange and networking.

Aug 21,2026

Qixiang Factory

Qixiang Factory

Dec 09,2025

视频标题